These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 34423416

  • 1. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Wilson SR, Sears M, Williams E, Drapekin J, Sivakumar I, Padrino S, Desai PC, Hager W, Manwani D, Clay LJ, Field JJ, Kanter J, Cohen AJ, Saif Ur Rehman S, Lanzkron S, Little JA, GRNDaD investigators.
    Br J Haematol; 2021 Dec; 195(5):e157-e160. PubMed ID: 34423416
    [No Abstract] [Full Text] [Related]

  • 2. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
    Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E.
    Blood; 2000 Jul 01; 96(1):76-9. PubMed ID: 10891433
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
    Pack-Mabien A, Brown B, Herbert DE, Haynes J.
    J Am Assoc Nurse Pract; 2015 Oct 01; 27(10):591-6. PubMed ID: 25711464
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM, Liem RI, Rigsby CK, Labotka RJ, DeFreitas RA, Thompson AA.
    Br J Haematol; 2016 Nov 01; 175(4):705-713. PubMed ID: 27507431
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Consequences and management of iron overload in sickle cell disease.
    Porter J, Garbowski M.
    Hematology Am Soc Hematol Educ Program; 2013 Nov 01; 2013():447-56. PubMed ID: 24319218
    [Abstract] [Full Text] [Related]

  • 10. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, Walker T, Nowicki MJ.
    J Pediatr Hematol Oncol; 2009 May 01; 31(5):309-12. PubMed ID: 19415007
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.
    Aygun B, Mortier NA, Kesler K, Lockhart A, Schultz WH, Cohen AR, Alvarez O, Rogers ZR, Kwiatkowski JL, Miller ST, Sylvestre P, Iyer R, Lane PA, Ware RE, Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) Trial Investigators.
    Br J Haematol; 2015 Apr 01; 169(2):262-6. PubMed ID: 25612463
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA, Adly AA, Ismail EA, Darwish YW, Ali Zedan M.
    Blood Cells Mol Dis; 2014 Dec 01; 53(4):189-93. PubMed ID: 25065856
    [Abstract] [Full Text] [Related]

  • 14. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A, Musallam KM, Wood JC, Sheikh-Taha M, Daou L, Taher AT.
    Eur J Haematol; 2009 Dec 01; 83(6):565-71. PubMed ID: 19737308
    [Abstract] [Full Text] [Related]

  • 15. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.
    Hilliard LM, Williams BF, Lounsbury AE, Howard TH.
    Am J Hematol; 1998 Sep 01; 59(1):28-35. PubMed ID: 9723573
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M, Ou P, Elie C, Canniffe C, Kutty S, Delos V, Graffigne C, de Montalembert M, Brousse V.
    J Pediatr Hematol Oncol; 2016 Oct 01; 38(7):497-502. PubMed ID: 27548334
    [Abstract] [Full Text] [Related]

  • 17. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.
    Ware RE, Schultz WH, Yovetich N, Mortier NA, Alvarez O, Hilliard L, Iyer RV, Miller ST, Rogers ZR, Scott JP, Waclawiw M, Helms RW.
    Pediatr Blood Cancer; 2011 Dec 01; 57(6):1011-7. PubMed ID: 21826782
    [Abstract] [Full Text] [Related]

  • 18. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D.
    Br J Haematol; 2004 Sep 01; 126(5):736-42. PubMed ID: 15327528
    [Abstract] [Full Text] [Related]

  • 19. Glycosylated ferritin as an improved marker for post-transfusion iron overload.
    Ishihara A, Yamauchi T, Ikeda K, Fukuyoshi Y, Yokoyama T, Yonemura Y, Uchiba M, Matsui H.
    Int J Hematol; 2021 Apr 01; 113(4):537-546. PubMed ID: 33400141
    [Abstract] [Full Text] [Related]

  • 20. Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network.
    Tsouana E, Kaya B, Gadong N, Hemmaway C, Newell H, Simmons A, Whitmarsh S, Telfer P.
    Eur J Haematol; 2015 Apr 01; 94(4):336-42. PubMed ID: 25138173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.